Evidence map›Paper›PMID 42851518›Full record

ArticleBiomaterials research2026

Vulnerability and Immunogenic Cell Death under Microwave Ablation for Synergistic Treatment of Hepatocellular Carcinoma.

Zide Chen, Hongwei Xu, Yufu Peng, Mengni Zhu, Linqing Huang, Feng Fang, Kefei Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomaterials research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zide ChenDepartment of Interventional Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangdong 510080, China.
Hongwei XuDivision of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Yufu PengDivision of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Mengni ZhuShanghai Key Laboratory of Magnetic Resonance, School of Physics and Electronic Science, East China Normal University, Shanghai 200241, China.
Linqing HuangThe Third Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Feng FangDepartment of Hepatobiliary Cancer, Liver Cancer Research Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Kefei ChenDivision of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.ORCID https://orcid.org/0009-0002-4437-3581

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microwave ablation (MWA) holds great promise for hepatocellular carcinoma but is often limited by incomplete tumor eradication and recurrence. Here, we report a tumor-killing nanoimmunoreactor driven by endogenous immune cues that synergizes with MWA to eliminate residual tumors and activate systemic antitumor immunity. The 17-AAG-MnO

Identifiers

PMID42851518
PMCPMC13646457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.